Diagnostic Industry Stakeholders Send Letter to Congress in Support of DAIA

A group of diagnostic manufacturers, laboratories and advocacy groups sent a letter to Congress yesterday urging lawmakers to act this year to enact legislation for modernizing oversight of clinical laboratory diagnostics, including laboratory-developed tests and in vitro diagnostics. “As stakeholders we stand ready to continue the work necessary to finalize a consensus diagnostic reform package this year,” the letter stated.

Source: https://www.360dx.com/clinical-lab-management/diagnostic-industry-stakeholders-send-letter-congress-support-daia